Robert M. Davis - May 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
CEO & President, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Robert M. Davis
Stock symbol
MRK
Transactions as of
May 3, 2022
Transactions value $
$0
Form type
4
Date filed
5/5/2022, 04:55 PM
Previous filing
Feb 28, 2022
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 248K May 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +228K $0.00 228K May 3, 2022 Common Stock 228K $87.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.